VSS, CPL, P-HG, HJLH, REP, PR, JSS and DZIC performed critical revision
For this review, our team spent over 115 collective hours conducting hands-on testing and research of Everlywells products and services, including a thorough investigation of its sample collection methods

Disclosures: Amrendra Kumar Sah: Nothing to Disclose, Teja Naveen Sata: Nothing to Disclose, Abdullah Mohit: Nothing to Disclose, Gopal Sharma: Nothing to Disclose, Md Ismail: Nothing to Disclose, Md Musa Hossain: Nothing to Disclose, Sarita Gupta: Nothing to Disclose, Sanal Madhusudana Girija: Nothing to Disclose, Senthil Venugopal: Nothing to Disclose 626 THE COMBINATION OF FATTY ACIDS DESATURASE 2 RS174583 AND PNPLA3 RS738409 POLYMORPHISMS IS A RISK FACTOR IN ADVANCED FIBROSIS IN METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE Shunsuke Ikejima 1 Kazuyoshi Kon 1 Kumiko Arai 1 Akira Uchiyama 1 Hiroo Fukada 1 Kyoko Fukuhara 1 Reiko Yaginuma 1 Maki Morinaga 1 Masahiro Tada 1 SHUNHEI YAMASHINA 1 Kenichi Ikejima 1 , 1 Juntendo University Graduate School of Medicine Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide

[DOI] [PMC free article] [PubMed] [Google Scholar] 362.Lambeth J.D., Cheng G., Arnold R.S., Edens W.A